Abbonarsi

Exploring factors associated with acquisition and chronicity of infection in bronchiectasis: A population-based study - 18/08/21

Doi : 10.1016/j.rmed.2021.106487 
Rashed Shkeiri a, 1, Walid Saliba b, g, 1, Nili Stein b, Ronza Najjar c, g, Gabriel Weber c, g, Shifra Ken- Dror d, Pninit Shaked- Mishan e, Yochai Adir a, g, Michal Shteinberg a, f, g,
a Pulmonology Institute Carmel Medical Center, Haifa, Israel 
b Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel 
c Infectious Diseases Unit, Carmel Medical Center, Haifa, Israel 
d Clinical Microbiological Laboratory, Central Laboratories Haifa & Western Galilee, Clalit Health Services, Haifa, Israel 
e Clinical Microbiology Laboratory, Carmel Medical CenterIsrael 
f CF Center, Carmel Medical Center, Haifa, Israel 
g Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel 

Corresponding author. Pulmonology Institute, Carmel Medical Center, 7 Michal St. Haifa 34362, Israel.Pulmonology InstituteCarmel Medical Center7 Michal St. Haifa 34362Israel

Abstract

Introduction

Chronic infection is associated with adverse outcomes among people with bronchiectasis. However, it is not known which factors are associated with a bacterial infection, and with persistence of an infection after the first episode. We aimed to determine factors associated with a new infection and with chronicity of Pseudomonas aeruginosa (PA) and H. influenzae (HI), the most common organisms in bronchiectasis infection.

Methods

Using an Israeli population database, we identified individuals diagnosed with bronchiectasis. Cox proportional hazard models were used to assess risk factors for first isolation and Logistic regression for chronicity of infection after a first isolation of PA and HI.

Results

We included 1305 people with a median of 5 respiratory samples per individual. PA was initially isolated in 297 people, of whom 97 (33%) developed chronic PA infection. HI was newly identified in 169 people, of whom 39 (23%) developed chronic infection (p = 0.029). Factors associated with increased risk of a new infection with PA were COPD (HR 1.87 [1.52–2.28], previous isolation of HI (HR 1.38 [1.07–1.78]), and alcohol abuse (HR 2.22 [1.13–4.3]). Younger age was associated with increased risk of HI infection, while COPD was associated with a lower risk of HI infection. Prescription of an anti- PA antibiotic was associated with chronic PA after a new infection (OR = 1.8 [1.09–2.9], p = 0.02). A landmark analysis showed that survival was worse in people with chronic PA infection vs. single or intermittent infection (Log rank: p = 0.034)

Conclusions

Younger age and presence of PCD are associated with a new isolation of HI. A new infection with PA is associated with previous HI infection, PCD, COPD, and alcohol abuse. Unexpectedly, treatment with appropriate anti-PA antimicrobials was not associated with a reduced risk of chronicity.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Bronchiectasis, Infection, Bacteria, Primary ciliary dyskinesia


Mappa


© 2021  Elsevier Ltd. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 185

Articolo 106487- agosto 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Worldwide production on sleep apnea from 2009–2018. Analysis of the ability to secure funding and international collaboration networks
  • Francisco García-Rio, Adolfo Alonso-Arroyo, José Ignacio de-Granda-Orive, Lourdes Castelló-Cogollos, Rafael Aleixandre-Benavent
| Articolo seguente Articolo seguente
  • Serum hepatocyte growth factor as a predictor of disease severity and future exacerbations in patients with non-cystic fibrosis bronchiectasis
  • Jong Hwan Jeong, Manbong Heo, Eun Ji Kim, Young-Sool Hah, I Re Heo, Tae Hoon Kim, Ho Cheol Kim, Sunmi Ju, Jung Wan Yoo, Yi Yeong Jeong, Jong Deog Lee, Seung Jun Lee

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.